Dr. Gerding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bldg 1 RM C344
Hines VA Hospital
Hines, IL 60141Phone+1 708-202-5689Fax+1 708-202-2684
Education & Training
- University of MinnesotaFellowship, Infectious Disease, 1973 - 1975
- University of MinnesotaResidency, Internal Medicine, 1971 - 1973
- Brigham and Women's HospitalInternship, Internal Medicine, 1968 - 1969
- University of Minnesota Medical SchoolClass of 1968
Certifications & Licensure
- IL State Medical License 1993 - 2026
- MN State Medical License 1969 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Publications & Presentations
PubMed
- A randomized controlled trial of efficacy and safety of Fecal Microbiota Transplant for preventing recurrent Clostridioides difficile infection.Dimitri M Drekonja, Aasma Shaukat, Yuan Huang, Jane H Zhang, Andrew R Reinink
Clinical Infectious Diseases. 2024-09-13 - How to develop a controlled human infection model for Clostridioides difficile.Annefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, Oleg Krut, Wilbur Chen
Clinical Microbiology and Infection. 2024-08-29 - The end of toxoid vaccine development for preventing Clostridioides difficile infections?Ed J Kuijper, Dale N Gerding
Clinical Infectious Diseases. 2024-08-24
Journal Articles
- BezlotoxumabDale Gerding, MD, Clinical Infectious Diseases
- Original Article Comparative Genomics Analysis of Clostridium Difficile Epidemic Strain DH/NAP11/106Dale N. Gerding, Dale N. Gerding, Egon A. Ozer, Egon A. Ozer, ScienceDirect
- Research Agenda for Microbiome Based Research for Multidrug-Resistant Organism Prevention in the Veterans Health Administration SystemDale N Gerding, Loreen Herwaldt, Daniel J Diekema, Nasia Safdar, Matthew Samore, Infection Control and Hospital Epidemiology
Press Mentions
- Destiny Pharma : Final ResultsApril 16th, 2021
- Epidemiologic Trends in Clostridioides Difficile Isolate Ribotypes in United States from 2011 to 2016May 5th, 2020
- Be Careful of Fecal Transplants, Warns FDA, After Patient DeathJune 14th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: